The American College of Gastroenterology estimates that between 10% and 15% of American adults suffer from irritable bowel syndrome but that only about 7% have received a diagnosis for it. The cause ...
Initially approved in 2012, linaclotide is already indicated for treating chronic idiopathic constipation and IBS-C in adults ...
Digestive woes like bloating and cramps often lead to confusion between IBS and IBD. While IBS is a functional disorder ...
Currently, treatment for irritable bowel syndrome with constipation (IBS-C) focuses on treating symptoms, preventing flares, and avoiding triggers. Lifestyle adjustments are common. These changes ...
The US medicines regulator has approved Linzess (linaclotide) capsules for children aged seven years and older with irritable ...
Nearly one-third of patients with irritable bowel syndrome (IBS) who underwent a novel behavior treatment developed by a UB behavioral scientist achieved significant relief within four weeks of ...